Generic Name and Formulations:
Ferric iron 210mg (equivalent to 1g ferric citrate); tabs.
Indications for AURYXIA:
To control serum phosphorus levels in patients with chronic kidney disease on dialysis.
Take with meals. Initially 2 tabs three times daily; titrate in decrements or increments of 1–2 tabs daily as needed at 1-week or longer intervals to maintain target levels; max 12 tabs/day.
Iron overload syndromes (eg, hemochromatosis).
Monitor serum phosphorus. Assess iron parameters (eg, serum ferritin, TSAT) prior to initiation and monitor during therapy. Inflammatory bowel disease. Active GI bleeding. Accidental iron overdose (esp. in children <6yrs); may be fatal. Pregnancy (Cat.B). Nursing mothers.
Concomitant IV iron; may require dose reduction or discontinuation of IV therapy. Give doxycycline at least 1hr before Auryxia. Give ciprofloxacin at least 2hrs before or after Auryxia. Concomitant drugs with narrow therapeutic range; consider monitoring.
Diarrhea, discolored feces, constipation, nausea, vomiting; iron overload.
- Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation
- Navigation Programs Most Effective in Increasing Follow-up Colonoscopy
- New Class of Clinical Trial Enhances Research on Cancer Care Delivery
- Specialized Interventions Reduce Aberrant Opioid Behaviors in Cancer Patients
- Nivolumab Provides Better Long-Term Efficacy Compared With Docetaxel in NSCLC
- Anticancer Properties of The Probiotic Kefir: A Review
- Navigating the Transition From Treatment to Breast Cancer Survivor
- Combining Radiation, Immunotherapy: An Emerging Challenge for Oncology Nursing
- Naldemedine Effective for Opioid-Induced Constipation in Cancer Pain
- Disruptions to Circadian Rhythm Linked to Prostate Cancer Surgery Regret
- Case Report of a KIT-mutated Melanoma Patient With an Excellent Response to Apatinib and Temozolomide Combination Therapy
- Novel Predictive Model More Effectively Identifies Risk for Lung Cancer
- Long-Term Eltrombopag Increases Platelet Counts, Decreases Bleeding in ITP
- Overall Survival Increase for Melanoma Brain Metastases
- Prophylactic Prochloperazine Ineffective for Opioid-induced Nausea/Vomiting in Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|